Genome-wide association studies have facilitated the construction of risk predictors for disease from multiple SNP markers. The ability of such 'genetic profiles' to predict outcome is usually quantified in an independent data set. Coefficients of determination (R 2 ) have been a useful measure to quantify the goodness-of-fit of the genetic profile. Various pseudo R 2 measures for binary responses have been proposed. However, there is no standard or consensus measure because the concept of residual variance is not easily defined on the observed probability scale. Unlike other non-genetic predictors such as environmental exposure, there is prior information on genetic predictors because for most traits there are estimates of the proportion of variation in risk in the population due to all genetic factors, the heritability. It is this useful ability to benchmark that makes the choice of a measure of goodness-of-fit in genetic profiling different from that of non-genetic predictors. In this study, we use a liability threshold model to establish the relationship between the observed probability scale and underlying liability scale in measuring R 2 for binary responses. We show that currently used R 2 measures are difficult to interpret, biased by ascertainment and not comparable to heritability. We suggest a novel and globally standard measure of R 2 that is interpretable on the liability scale. Further, even when using ascertained case-control studies that are typical in human disease studies, we can obtain a R 2 measure on the liability scale that can be compared directly to heritability.
INTRODUCTION
The discovery of multiple genetic loci that are associated with disease and other complex traits has sparked an interest in making individual risk predictions from genetic data [Demirkan, et al. 2010; Evans, et al. 2009; Kraft, et al. 2009; Lyssenko, et al. 2008; Pharoah, et al. 2008; Purcell, et al. 2009 ; The International Multiple Sclerosis Genetics 2010; Wray, et al. 2007; . The genetic risk of healthy individuals can be predicted from their measured genotype at multiple loci, and, since the total (phenotypic) risk is correlated with genetic risk, a prediction can be made of total risk from genetic data. Typically, the effects of measured genotypes on disease are estimated in one or more discovery samples, and those estimated effects are then combined with the genotypes at one or more independent validation samples that contain affected and unaffected individuals. For each individual in the validation sample, a genetic profile is calculated and these profiles are correlated with outcome (affected / unaffected) to quantify the precision of the genetic risk predictor.
What is a good measure to quantify the goodness-of-fit of the genetic profile? Unlike other non-genetic predictors such as environmental exposure, there is prior information on genetic predictors because for most traits there are estimates of the proportion of variation in risk in the population due to all genetic factors, the heritability. From the heritability we can calculate the maximum precision of a genetic profile, i.e. the precision if all causal variants were known and their effect sizes known without error [Wray, et al. 2007; ].
Therefore, we have a natural benchmark in that we can compare the fit of the genetic profile in the validation sample to the heritability. It is this useful ability to benchmark that makes the choice of a measure of goodness-of-fit in genetic profiling different from that of nongenetic predictors.
Coefficients of determination (R 2 ) for binary responses have been used in measuring the goodness of fit of models containing genetic predictors of human disease [Baneshi, et al. 2010; Barrett, et al. 2009; Barrett, et al. 2008; de Cid, et al. 2009; Demirkan, et al. 2010; Gharavi, et al. 2011; Janssens, et al. 2011; Labruna, et al. 2010; Lyssenko, et al. 2008; Painter, et al. 2011; Purcell, et al. 2009; Richards, et al. 2011; Sarafidis, et al. 2007; Shea, et al. 2010; Study 2010; Tassone, et al. 2000; The International Multiple Sclerosis Genetics 2010; Vaidya, et al. 2010; Witte and Hoffmann 2011] . In the statistical literature, various pseudo R 2 measures for binary responses have been proposed [Cox and Snell 1989; DeMaris 2002; Efron 1978; McFadden 1974; McKelvey and Zavoina 1975; Nagelkerke 1991; Veall and Zimmermann 1996] . However, there is no standard or consensus measure because the concept of residual variance is not easily defined on the observed disease scale [Menard 2000; Nagelkerke 1991 ]. Most of the pseudo R 2 measures use the likelihood functions in logistic or probit models that are based on the observed disease scale. This causes the obtained R 2 to be far different from its value on the underlying liability scale, and therefore obscures comparisons with heritability since the latter is usually expressed on the scale of liability. Furthermore, most case-control studies from which the precision of genetic profiles are estimated are ascertained, and traditional R 2 measures are not invariant with respect to ascertainment because they are based on goodness-of-fit of the actual (ascertained) data. This complicates a comparison with other studies or inference about the population. In the literature, the effect of ascertainment has been poorly addressed or ignored [Barrett, et al. 2009; Barrett, et al. 2008; Cubiella, et al. 2010; Kochi, et al. 2010; Peel, et al. 2006; Peel, et al. 2007 ].
In addition to an R 2 statistic to measure the goodness-of-fit of a genetic profile, the area under the curve (AUC) of receiver-operator characteristic (ROC) is frequently used to assess the precision with which a genetic predictor can correctly classify individuals into those that will become affected and those that won't. ROC curves have an advantage that they are not affected by ascertainment of the sample in which the goodness-of-fit of the genetic predictor is tested. Although the AUC can be interpreted as an R 2 on the liability scale , the AUC statistic does not provide a direct measure of how well the predictor performs relative to capturing all genetic variation or relative to the maximum value it can attain from genetic data .
In this study, we use a liability threshold model to establish the relationship between the probability of disease on the observed scale and an underlying scale of liability. We propose a novel measure of R 2 that is based upon a transformation between the observed probability scale and underlying liability scale. The R 2 on the liability scale can be obtained from a linear, logit or probit model. Further, we are interested in obtaining an R 2 at the population level even when the validation sample is ascertained. We used a modified version of the transformation between the observed and liability scale which corrects for bias due to ascertainment in case-control studies. Therefore, we obtain a R 2 measure on the scale of liability that can be compared directly to heritability.
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MATERIALS AND METHODS
Relationship between the observed probability scale and the probit or logit liability scale
Liability of disease is assumed to be the sum of environmental and additive genetic factors that are sampled from independent normal distributions. The model for liability can be written as,
where l i is the liability "phenotype" for the ith individual μ is the overall mean, g i the random genetic effect on the liability scale and e i is the residual. For most of the theoretical derivations and simulations we make the distributional assumptions that g and e are independently normally distributed with variances 2 g  and 2 e  . For the theoretical validation and analyses of simulated data, we used g i as an explanatory variable in linear, probit or logistic models to validate the relationship between the observed disease scale and underlying liability scale. For real data, where g i is not observed, we can use its estimate generated from genetic marker data and effect sizes estimated from independent data [Baneshi, et al. 2010; Barrett, et al. 2009; Gail 2008; Lyssenko, et al. 2008; Purcell, et al. 2009; Wacholder, et al. 2010 ]. In the Discussion section we discuss the consequences of estimating g with error.
Liability l is ~N(0,1), and the proportion of variance on the liability scale due to the genetic profile is
In the liability threshold model, all affected individuals have a liability phenotype exceeding a certain threshold value t. This leads to observations (y) that are 0 or 1 for unaffected and affected individuals, with a Bernoulli distribution with a probability, p, i.e.
y ~ Bern(p).
7 For analysis of data, a generalised linear model can be used to link probabilities to effects on a linear scale. Using a logit link, the probability of disease p i for individual i can be written as a function of linear predictors as,
where g i is an explanatory variable and a measure of genetic value for an individual; for theoretical validation and analyses of simulated data we used the g i defined in (1) 
(
Similarly, a probit model is,
where Φ is the standard cumulative density function, and probit  and probit b are regression coefficients for the mean and genetic effects estimated in a probit model. The log-likelihood for the probit model is,
Under the null model without the genetic effects, the probability can be expressed as
where K is the mean proportion of cases in the sample, and the likelihood for the null model is,
(4)
In the classical liability threshold model (1), the probability of an individual being affected given his or her genetic value can be derived using normal distribution theory [Dempster and Lerner 1950] , hence assuming that total liability follows a normal distribution. The relationship with the probit estimates of the parameters is,
Dempster and Lerner [Dempster and Lerner 1950] showed that the additive genetic value expressed as a probability on the observed disease scale can be written as a linear function of the additive genetic value on the liability scale,
where c is a constant, u is the genetic value on the observed scale, and μ obs and b obs are regression coefficients for the mean and genetic effects on the observed scale estimated in a linear model with 0, 1 observations. According to the Robertson transformation (1950), the regression coefficient for the genetic effects is the same as the probability density at the
where m is the mean liability for cases and z is the height of a normal density curve at the point that truncates the proportion K in the upper tail. Therefore, the likelihood equations (2) 
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Pseudo R 2 measures based on the likelihood function
The linear approximation of the likelihood function (6) implies that the likelihood function is based on probabilities on the observed disease scale, and not based on the logit or probit liability scales. This explains why pseudo R 2 based on the likelihood [Cox and Snell 1989; McFadden 1974; Nagelkerke 1991] do not give an appropriate interpretation when measuring the goodness of fit of the linear predictor for the logit ( ). Since observations and underlying explanatory factors are not on the same scale for binary traits, it has been observed that the pseudo R 2 based on the likelihood never reach one even when a model has a perfect fit [Cox and Snell 1989; Nagelkerke 1991] . For example, the R 2 proposed by Cox and Snell (C&S) is,
is the mean squared ratio of the probability explained by random chance (i.e. the numerators) over that explained by random chance plus additional genetic factors (i.e. the denominators), which are obviously on the observed probability scale.
In a linear model with 0,1 responses on the observed probability scale, the numerators are analogous to the mean squared errors in the full model, i.e. y = μ + g + e, and the denominators are analogous to the mean squared errors in the null model, i.e. y = μ + e.
can be approximated as,
where 2 e  is estimated residual variance on the observed probability scale which is a proportion of the total variance unexplained by the genetic factor. If liability is normally distributed then the variance on the observed scale removed by the genetic profile is approximately equal to 2 2 l h z and the total variance on the observed scale is K(1-K), so that the residual on that scale is the difference between the two. Therefore, an approximation of the expectation of 2 &S C R can be written as,
This expression shows why Cox and Snell's R 2
is approximately equal to R 2 on the observed scale in a linear model, although the difference increases with extremely high heritability [Cox and Wermuth 1992] (also see Table 1 ). Nagelkerke [Nagelkerke 1991 ] tried to correct Cox and Snell's R 2 by scaling it by the maximum value it can ever attain, i.e.
from (4). However, this adjustment is not appropriate if the aim is to measure the goodness of fit of models on the scale of liability.
R 2 on the liability scale
In order to derive R 2 on the liability scale, we first obtain the R 2 on the observed scale using linear regression. In a linear model with 0, 1 observation, the R 2 on the observed probability scale can be written as,
11 where ) var( can be transformed to that on the liability scale using the Robertson transformation [Dempster and Lerner 1950] ,
This concept of R 2 on the liability scale can be simply extended to probit or logit models. In a probit model, the R 2 on the probit liability scale can be directly obtained as the variance explained by linear predictors as a proportion of the total variance on the probit liability scale, that is,
where the residual variance is defined as var(e) = 1 in the probit model. Since the assumption of normality on the scale of liability is assumed for both (8) and (9), their expectations are identical. Equation (8) is based upon an analysis on the 0-1 scale followed by a transformation whereas Equation (9) is based upon a generalized linear model analysis.
Similarly, assuming that the liability has a logistic distribution, R 2 on the logit liability scale can be obtained with the residual variance of var(e) = π 2 / 3 = 3.29 as,
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McKelvey and Zavoina [McKelvey and Zavoina 1975] were the first to propose an R 2 measure expressed on an underlying latent scale using a generalized linear model. Equation (9) implements this for the probit link function and Equation (10) for the logit link function, and this R 2 is widely used. The derivation for the liability threshold model has not been considered previously (Equation (8)). Although the threshold model and the generalized linear model are equivalent the formulae for R 2 in Equations (9) and (10) are different to that in Equation (8). R 2 values from Equations (9) and (10) are based on estimated linear predictors in logit or probit models, whereas that from Equation (8) was based on a transformation from R 2 on the observed scale which was based on the likelihood. Importantly, the transformation in Equation (8) can be modified to correct bias in ascertained case-control studies (see next sections).
R 2 on the liability scale from AUC
AUC is a useful statistic of the precision of predicting the genetic risk of disease [Janssens, et al. 2006; ]. Using estimated AUC, R 2 on the liability scale can be obtained . Estimation in this approach is independent of the relative proportion of cases and controls even if there is ascertainment in the case-control study. However, the estimation become less accurate for high heritabilities . Given K and AUC, R 2 can be obtained as,
Where Q = Φ -1 (AUC), and m 2 = -mK/(1-K) .
R 2 on the liability scale for ascertained case-control studies
In genetic epidemiology studies, case-control designs are widely used where cases are usually over-sampled relative to the prevalence in the population. In this situation, there is no R 2 measure that is estimated on the liability scale and corrects for ascertainment. We consider the same liability model (1) but when samples are ascertained in a case-control study.
According to (5), the genetic value on the observed scale (u cc ) for an individual in a casecontrol study is,
, where P is the proportion of cases in the case-control sample. The details of this derivation are in Appendix A. From (12), the variance explained by the genetic factor on the observed scale is ], 2 2 2 2 2 2 2 2 2 2 2 ) 1 (
As 2 o R is a proportion of the total variance explained by the genetic factor on the observed probability scale (7), 2 cc o R is that proportion for an ascertained case-control study. Therefore,
As a portion of the total variance explained by the genetic factor on the liability scale (8) corrected for ascertainment, 2 cc l R can be derived from (14) as (Appendix A),
where ) 1 (
14 To summarise the theoretical sections, we have derived an expression for the proportion of variation in liability explained by the genetic profile in the population, using an estimate of the proportion of variation explained by the profile on the observed 0-1 scale in an ascertained case-control sample. The expression (Equation (15)) uses the goodness-of-fit R 2 on the 0-1 scale and then transforms it to the liability scale whilst adjusting for ascertainment.
Simulation study
In a simulation study, genetic (g) and residual values (e) were independently generated from random normal distributions with means of zero and variances of 2 g  and 2 e  , respectively.
The value for 2 e  was chosen such that the desired proportion of variation in liability due to the genetic profile was obtained. Liability for each individual was l = g + e. Disease status for each individual was determined by comparing l with the threshold of liability determined by the population prevalence. In this study, a population prevalence K=0.5, 0.1 or 0.01 was used with 10,000 individual observations. Therefore, for the case-control designs, we had samples of 5000, 1000 and 100 cases and 5000, 9000 and 9900 controls for K = 0.5, 0.1 and 0.01, respectively. When testing ascertained samples, cases were over-sampled such that the number of cases and controls was approximately equal, i.e. P=0.5. So for the ascertained case-control designs, we had samples of 5000 cases and 5000 controls for K = 0.1 or 0.01. In an alternative simulation, genetic and residual values were independently generated from logistic distributions with a means of zero and variances of 2 For analyses of the simulated data, we used a linear, logit or probit model where disease status was used as 0, 1 observations (y), and genetic values on the liability scale were used as explanatory variables [Cox and Wermuth 1992] . Using those models, we obtained several kinds of R 2 measures (Table 1) . First, we obtained 2 o R from a linear regression using (7).
Second, we used Cox and Snell's method [Cox and Snell 1989] . Third, we used Nagelkerke's scale method [Nagelkerke 1991 ]. Fourth, we transformed 2 o R to 2 l R on the liability scale using (8). Fifth and sixth, we used the variance explained by linear predictors proportional to the total variance on the probit (9) and logit scale (10), respectively. Seventh, we obtained 2 AUC R from AUC estimated from a probit model (a linear or logit model gave the same results) using (11). These methods and notations are briefly described in Table 1 , and pseudo R-codes for them are shown in the Appendix B. In testing ascertained case-control samples, all the same methods were applied except that 2 cc o R was transformed to 2 cc l R using (15).
RESULTS
Estimated R 2 measures using several methods with simulated data
In Figure 1 (Figure 1) . Using a logistic distribution, we also tested and estimated R 2 values for ascertained case-control studies (Logit, K<P in Figure 1 ). In this situation, no method gave correct estimates. Again, a weighting scheme in a logistic model can be used to produce unbiased estimates for the logistic distribution (Appendix C).
Comparing observed and expected values
The expected value for each R 2 can be obtained as described in Table 1 which gives approximate relationships between the R 2 values. 
DISCUSSION
It is reasonable to assume that there is underlying liability for complex disease [Falconer and Mackay 1996] , and recent empirical findings from genome-wide association studies are consistent with highly polygenic models for common disease [Antoniou and Easton 2003; Pharoah, et al. 2002; Purcell, et al. 2009 ; The International Multiple Sclerosis Genetics 2010;
Witte and Hoffmann 2011]. If this assumption is valid, it is desirable to have coefficients of determination on the same scale as liability because then the goodness-of-fit can be compared across studies and traits. We showed that pseudo R 2 statistics based on the likelihood function (e.g. 2 &S C R ) are on the observed probability scale. This is the reason why such R 2 are inappropriate to measure the goodness of fit of models, i.e. it never reaches unity even when there is a perfect model fit. Nagelkerke R 2 is adjusted for the maximum value so that it may reach unity, however the adjustment is inappropriate to measure the goodness of fit of models on the liability scale. We derived and showed the relationship between the observed probability scale and the underlying liability scale. was violated when the true liability had a logistic distribution (Figure 1 ). If liability is the sum of many multiple independent random genetic and environmental factors, then the central limit theorem predicts that its distribution will tend to normality [Falconer and Mackay 1996; Gibson 2009; Valentin 1999; . For this reason the assumption of a normal distribution for liability to common disease seems reasonable.
In practice, with real data, genetic values on the liability scale are not observed (g i ) but estimated ( i ĝ ). For example, i ĝ can be created from validated genome-wide significant SNPs or else from a large number of SNPs with effect sizes estimated in an independent discovery sample in a 'profile scoring' approach [Chen, et al. 2011; Meigs, et al. 2008; Morrison, et al. 2007; Purcell, et al. 2009; The International Multiple Sclerosis Genetics 2010; Wacholder, et al. 2010; Wray, et al. 2007 ]. In these examples, effect sizes are estimated in a fixed effects framework, and the resulting predictor will be estimated with error ( i  ), such that
. The effect of such errors on the R 2 values investigated in this study is that the 'heritability' of the predictor is lower than if it were estimated without error, and so the R 2 values will be lower. However, all calculations and simulations results are still valid if the variation in liability explained by ĝ is substituted for the heritability of liability. If the predictor is estimated from random effects models and unbiased in the sense that the 20 regression of i g on i ĝ is unity [Goddard, et al. 2009 ] then the R 2 values will be unbiased and will reflect the proportion of variance of liability explained by i g .
We values, adjusted for ascertainment bias, is a useful measure with desirable properties.
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Appendix A: Transformation corrected for ascertainment
In ascertained case-control studies, the mean and variance for case/controls disease status (y cc ), disease liability (l cc ) and genetic liability (g cc ) following quantitative genetic theory [Falconer and Mackay 1996] are, E(y cc ) = P, which is the proportion of cases in the sample, var(y cc ) = P (1 -P) , which is the phenotypic variance on the observed scale in the case-control
The mean of genetic liability depends on the mean liability phenotype of the cases and the heritability of liability,
Similarly, the variance for genetic liability can be derived as,
For Equation (12) 
The term 
, and ) 1 ( , the 2 probit R from Equation (9) is still biased because there are still over-sampled cases in the estimation. We used a proportion of cases, i.e. (1-P)K/[P(1-K)], such that the number of cases and controls matched the population incidence, and estimated 2 probit R using Equation (9). The pseudo R-code for these processes is in the following.
# Weighted R2 from a weighted probit model wv=(1-P)K/[P(1-K)]
#weighting factor wt=y+1 wt[wt==2]=wv #weighting array pmv=glm(y~g,weights=wt, family=binomial(probit)) #weighted probit model vr=runif (nt,0,1) #uniform random values vsel=pmv$linear.predictors [y==control | vr<wv] #select controls and a proportion (wv) of cases R2=var(vsel)/(var(vsel)+1)
In contrast to a probit model, estimates from a logistic model are not affected by sample ascertainment because the estimate is a function of odds ratios (Equation (2)). Therefore, we could obtain unbiased logit b from a standard logistic regression. However, 2 logit R from Equation (10) is biased because of over-sampled cases in the estimation. We used the same strategy as above to use a proportion of cases, i.e. (1-P)K/[P(1-K)], and estimated 2 logit R using
Equation (10). The pseudo R-code for obtaining weighted 2 logit R is in the following.
# Weighted R2 from a logistic model lrmv=glm(y~g,family=binomial(logit)) # logistic model vr=runif (nt,0,1) #uniform random values vsel=lrmv$linear.predictors[y==control | vr<wv] #select controls and a proportion (wv) of cases R2=var(vsel)/(var(vsel)+pi^2/3) Weighted R 2 was estimated and compared to the transformation method (Table S1 and S2). For simulations using a normal distribution of liability, weighted R 2 from a weighted probit model was estimated (Table S1 ). For simulations using a logistic distribution, weighted R 2 from a standard logistic model was obtained (Table S2 ). Table S1 shows that weighted R 2 from the weighted probit estimates was much better than that from the unweighted probit estimates when using simulations of a normal distribution of liability. The performance of the weighted probit estimates was similar to that of transformation method ( 2 cc l R ) (Table 1 main text) although the standard deviations for the weighted R 2 were larger. When using simulations of a logistic distribution of liability, the weighted R 2 from a logistic model gave unbiased estimates, which were close to the true values (Table S2 ). The expectation was obtained as described in Table 1 .
Standard deviation over 30 replicates is in the bracket. The expectation was obtained as described in Table 1 .
Standard deviation over 30 replicates is in the bracket. Weighted estimates from a logistic model are close to the true values. 
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